German generic drugmaker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday. Skip to main content ...

The alliance covers cancer drugs that will lose patent protection between 2016 and 2020. Photo: Mint Frankfurt: German generic drug maker Stada struck an alliance with family-owned Hetero Drugs ...

Hetero Drugs in oncology deal with German co Stada. SENSEX 81,596.63 + 410.19. NIFTY 24,813.45 + 129.55. CRUDEOIL 5,298.00 ... Other Products. STEP Images Classifieds ...

The subsidiary firm, Hetero Healthcare, has strong product portfolios in Hepatitis, HIV and Oncology segments. Last year, Hetero launched path-breaking Hepatitis C drugs Sofosbuvir along with ...

PARSIPPANY, N.J., June 19, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Kissei Pharmaceutical Co., LTD today confirmed that they have filed lawsuits against Sandoz Inc., Hetero USA, Inc ...

Oasmia Pharmaceutical AB develops, manufactures, markets and sells new generations of drugs in the field of human and veterinary oncology. The company’s product development aims to create and ...

Oasmia Pharmaceutical AB (NASDAQ: OASM) has entered into a new exclusive marketing and distributions agreement with Hetero Group (Hetero) with the goal of driving revenue in Russia and other CIS ...

German generic drugmaker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday. Skip to main content ...

German generic drugmaker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday. As part of the agreement in ...

German generic drugmaker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday. As part of the agreement in ...

As part of the agreement in principle, with details yet to be hammered out, Stada will get exclusive marketing rights in Europe for generic oncology drugs developed and produced by Hetero.

German generic drugmaker Stada struck an alliance with family-owned Hetero Drugs Ltd of India to gain access to active ingredients for cancer drugs, Stada said on Thursday. As part of the agreement in ...